Navigation Links
ADVENTRX Announces Further Cost-Cutting Measures
Date:1/5/2009

in the U.S. to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, and approved in the European Union to treat non-small cell lung cancer and advanced or metastatic breast cancer.

About ANX-514 (docetaxel emulsion)

ANX-514 is a novel nano-emulsion formulation of the chemotherapy drug docetaxel, which is marketed under the brand name Taxotere. ANX-514 is formulated without polysorbate 80 or other detergents and is intended to reduce the severity and/or incidence of hypersensitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. Immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat breast, non-small cell lung, prostate, gastric and head and neck cancers.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. The Company seeks to improve the performance and commercial potential of existing treatments by addressing problems associated with these treatment regimens. In December 2008, the Company announced that it is exploring a range of strategic options, including the sale or disposition of one or more of its product candidate programs, a strategic business merger and other transactions that maximize the value of the Company's assets. More information can be found on ADVENTRX's web site at www.adventrx.com.

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. ADVENTRX Exploring Strategic Options
2. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
3. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
4. ADVENTRX Announces Restructuring and Cost Reduction Initiatives
5. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
6. ADVENTRX Settles Dispute With Former Licensee
7. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. ADVENTRX Appoints Vice President of Manufacturing
9. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
10. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
11. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
(Date:12/14/2009)... Rep. Patrick Kennedy Joins with State Biotech ... Leadership in Research and Development while Boosting ... Industry ,, PROVIDENCE, R.I., Dec. 14 ... prominent leaders in research, medicine and biotechnology ... Facility to discuss the importance of medical ...
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
(Date:12/14/2009)... of Brookfield Engineering’s Powder Flow Tester – helping Brookfield move ... footprint and more compact design. , ... ... US-based thermoforming company, has completed the delivery of Brookfield Engineering’s ... to a plastic enclosure with a smaller footprint and more ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2
... DOESN,T Keep Them Waiting, WASHINGTON, April 16 ... Capitol Hill to meet with members of,Congress, The Coalition ... ad urging members to keep the best interests of,patients ... workable approval,pathway for safe, effective and affordable biogeneric medicines., ...
... 16 Biotech and pharma,companies are increasingly relying ... Genetic Engineering & Biotechnology News (GEN). The,technique can ... testing drug,candidates for toxic effects, according to an ... http://www.genengnews.com/articles/chitem.aspx?aid=2437 )., "Better screening technologies, noninvasive monitoring, ...
... NORTH VANCOUVER, April 16 /PRNewswire-FirstCall/ - Chromos Molecular,Systems Inc. ... on its on-going restructuring efforts., The Board of ... stepped down as President and Chief Executive Officer, effective,immediately. ... Mr. Duncan, a,founder of the Company, served as President ...
Other Biology Technology:Diverse Coalition of Purchasers Respond to BIO CEO Fly-In: There is Another Side to The Story 2Genetic Engineering & Biotechnology News Reports on Growing Use of Cell-Based Assays 2Chromos provides shareholder update 2
(Date:12/15/2009)... exact an enormous emotional and economic toll on society. ... rip currents each year in U.S. waters and it,s likely ... worldwide. A serious disconnect exists between rip current research ... rip tides and undertows, and more importantly, most people do ... a rip current. , The goal of the Rip Current ...
(Date:12/14/2009)... are part of an international team that has used ... revise the history of North America,s woolly mammoths and ... Earth and Atmospheric Sciences professor Duane Froese and his ... dating of bones and teeth. That analysis concluded that ... America (the ,megafauna,) disappeared about 13,000 years ago. ...
(Date:12/14/2009)... as a clean-burning, renewable fuel that could help wean ... caused by ozone, compared with gasoline, especially in winter, ... , Ozone production from both gasoline and E85, ... percent ethanol, is greater in warm sunny weather than ... because heat and sunlight contribute to ozone formation. But ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 1Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 2Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 3Rabies 3A How to Protect Yourself and Your Pets 51990 1Rabies 3A How to Protect Yourself and Your Pets 51990 2Sanford Rose Associates Opens Minneapolis Office 13075 1Sanford Rose Associates Opens Minneapolis Office 13075 2
... leading study that has implications for the development of ... ovarian cancers that have lost the expression of a ... the loss of the GPC3 gene induces overgrowth through ... cancer growth. , Published today in Developmental Cell, the ...
... May 12, 2008 There exists much ethical controversy brought ... to religion. In a new essay in The Journal of ... medical ethics that draws upon Jewish texts, traditions, and philosophy ... of this faith tradition. , Genetic explanations for how ...
... new project (RevGenUK) is being launched at the John Innes ... , This knowledge can be used to improve the ... grow more sustainably with reduced nitrogen fertilisers. , ... and Biological Sciences Research Council (BBSRC), the project builds on ...
Other Biology News:Religion and the narrative of biological science 2
Dnase and Rnase free...
...
... Well BAC Prep; Ideal for ... 1.5ml 2xYT cultures; Provides high-quality ... sequencing for small to large ... which minimizes shearing and improves ...
Hybridization Buffer 3.6 ml...
Biology Products: